Published in Am Rev Respir Dis on June 01, 1987
Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest (2007) 1.86
A simple procedure for measuring pharyngeal sensitivity: a contribution to the diagnosis of sleep apnoea. Thorax (2005) 0.87
Frequency analysis of snoring sounds during simulated and nocturnal snoring. Eur Arch Otorhinolaryngol (2008) 0.85
Upper airway sensory function in children with obstructive sleep apnea syndrome. Sleep (2010) 0.83
Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius. Sleep Disord (2012) 0.80
Upper Airway Vibration Perception in School-Aged Children with Obstructive Sleep Apnea. Sleep (2016) 0.75
A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry (1995) 3.65
Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol (1996) 3.52
Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.91
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Ther (2008) 1.88
Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med (1984) 1.88
Pathophysiology of obstructive sleep apnoea. Eur Respir J (1995) 1.85
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med (1998) 1.84
Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J (2000) 1.80
Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med (1997) 1.76
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax (2009) 1.45
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 1.43
Does pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet (1982) 1.43
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Ther (2008) 1.41
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene Ther (2009) 1.40
Diffuse panbronchiolitis: East meets West. Eur Respir J (2007) 1.40
Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest (2000) 1.35
Evidence of genetic resistance of cattle to infection with Mycobacterium bovis. J Dairy Sci (2010) 1.32
Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev (2008) 1.30
Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med (2000) 1.27
Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest (1996) 1.22
High prevalence of familial sarcoidosis in an Irish population. Thorax (1984) 1.20
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Is sleep apnoea more common in North America? Lancet (1982) 1.14
Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax (1980) 1.14
Recovery from severe paraquat poisoning following forced diuresis and immunosuppressive therapy. J Ir Med Assoc (1971) 1.12
Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry (2006) 1.12
Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias. Postgrad Med J (1994) 1.11
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax (1988) 1.10
Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J (2001) 1.10
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene Ther (2012) 1.08
alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis (1993) 1.08
Enhancement of seed oil content by expression of glycerol-3-phosphate acyltransferase genes. Biochem Soc Trans (2000) 1.07
Meconium ileus equivalent in older patients with cystic fibrosis. Br Med J (Clin Res Ed) (1983) 1.07
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J (2002) 1.07
Lancefield group C streptococcal endocarditis. Thorax (1974) 1.05
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma. Oncogene (2011) 1.04
Granulomatous hepatitis of obscure aetiology. Diagnostic contribution of Kveim testing and anti-tuberculous therapy. Q J Med (1971) 1.02
Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest (1997) 1.01
Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax (1989) 1.01
Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol (1985) (1996) 1.00
Acute stridor due to an upper tracheal membrane following endotracheal intubation. Eur Respir J (1999) 1.00
The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction. Eur Respir J (2008) 0.99
The role of Hispanic race/ethnicity and poverty in breast cancer survival. P R Health Sci J (1995) 0.99
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J (1999) 0.98
Reflex respiratory response to changes in upper airway pressure in the anaesthetized rat. J Physiol (2001) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet (2001) 0.97
Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 0.96
Fatal recurrence of neuroleptic malignant syndrome. Br J Psychiatry (1988) 0.95
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer. Cell Death Dis (2013) 0.95
The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol (1989) 0.95
Altered gastrointestinal immune response in sarcoidosis. Gut (1988) 0.95
Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J (1995) 0.94
A prospective study to identify high-yield criteria associated with acute intracranial computed tomography findings in head-injured patients. Am J Emerg Med (1993) 0.94
Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis. Ann Rheum Dis (2010) 0.93
Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK. Br J Ophthalmol (2000) 0.93
Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med (1998) 0.93
Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax (2004) 0.93
The changing profile of tuberculosis in a general teaching hospital--a five-year review of 121 cases. Ir Med J (1982) 0.93
A one-year prospective audit of an asthma education programme in an out-patient setting. Ir Med J (1997) 0.92
Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J (2011) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest (1992) 0.90
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. Int J Cancer (2013) 0.90
Comparison of three auto-adjusting positive pressure devices in patients with sleep apnoea. Eur Respir J (2006) 0.89
Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea. Am Rev Respir Dis (1982) 0.88
Genetic parameters for production, health, fertility and longevity traits in dairy cows. Animal (2012) 0.87
Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense. Hypertension (1997) 0.86
Tuberculin sensitivity and the BCG scar in tuberculosis contacts. Tuber Lung Dis (1995) 0.86
Organochlorine chemicals in tree swallows nesting in pool 15 of the Upper Mississippi River. Bull Environ Contam Toxicol (2000) 0.86
Recovery: what mental health nurses and service users say about the concept of recovery. J Psychiatr Ment Health Nurs (2011) 0.85
Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J Natl Cancer Inst (2001) 0.85
Comparison of a limited computerized diagnostic system (ResCare Autoset) with polysomnography in the diagnosis of obstructive sleep apnoea syndrome. Eur Respir J (1996) 0.85
Ventilation and gas exchange during sleep and exercise in severe COPD. Chest (1996) 0.85
Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis (1983) 0.85
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J (2009) 0.85
Biliary complications of cystic fibrosis. Gut (1992) 0.84
Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest (1991) 0.84
Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks. Thorax (1995) 0.84
Honeycomb cysts in idiopathic pulmonary haemosiderosis: high-resolution CT appearances in two adults. Br J Radiol (2008) 0.84
Diagnostic criteria for the sleep apnoea syndrome: time for consensus. Eur Respir J (1996) 0.84
Neutrophils from AIDS patients treated with granulocyte colony-stimulating factor demonstrate enhanced killing of Mycobacterium avium. J Infect Dis (1998) 0.84
Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia. J Med Genet (2006) 0.83
Effects of nasal airflow on breathing during sleep in normal humans. Am Rev Respir Dis (1993) 0.83
Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. Prostate (2007) 0.83
Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8. Exp Lung Res (2002) 0.83
Prolonged spontaneous pneumomediastinum in adult dermatomyositis. Ann Rheum Dis (1987) 0.83
Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis (1986) 0.82